Gilead Sciences Inc Allovir, Inc. (ALVR) insider trading activity
Gilead Sciences Inc is > 10% Shareholder of Allovir, Inc.. Currently has a direct ownership of 16.6 Million shares of ALVR, which is worth approximately $14.8 Million. The most recent transaction as insider was on Jun 27, 2023, when has been sold 2,930,870 shares (Common Stock) at a price of $3.75 per share, resulting in proceeds of $10,990,762. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
16.6M
0%
3M change
0%
12M change
Total Value Held
$14.8 Million
GILEAD SCIENCES INC Transaction History
Also insider at
GSI
Gilead Sciences Inc
> 10% Shareholder
Foster City, CA